Rostène WH - Search Results

1

Central administration of the neurotensin receptor antagonist, SR48692, modulates diurnal and stress-related hypothalamic-pituitary-adrenal activity.

Rowe WB, Nicot A, Sharma S, Gully D, Walker CD, Rostène WH, Meaney MJ, Quirion R. Rowe WB, et al. Among authors: rostene wh. Neuroendocrinology. 1997 Aug;66(2):75-85. doi: 10.1159/000127223. Neuroendocrinology. 1997. PMID: 9263204

2

Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists.

Nicot A, Bérod A, Gully D, Rowe W, Quirion R, de Kloet ER, Rostène W. Nicot A, et al. Neuroendocrinology. 1994 Jun;59(6):572-8. doi: 10.1159/000126707. Neuroendocrinology. 1994. PMID: 8084381

3

Endogenous neurotensin regulates hypothalamic-pituitary-adrenal axis activity and peptidergic neurons in the rat hypothalamic paraventricular nucleus.

Nicot A, Rowe WB, De Kloet ER, Betancur C, Jessop DS, Lightman SL, Quirion R, Rostène W, Bérod A. Nicot A, et al. J Neuroendocrinol. 1997 Apr;9(4):263-9. doi: 10.1046/j.1365-2826.1997.00581.x. J Neuroendocrinol. 1997. PMID: 9147289

4

Changes in vasoactive intestinal Peptide binding site densities in the female rat central nervous system and pituitary during lactation.

Viau V, Montagne MN, Sarrieau A, Meaney MJ, Rostène W. Viau V, et al. J Neuroendocrinol. 1992 Dec;4(6):759-64. doi: 10.1111/j.1365-2826.1992.tb00228.x. J Neuroendocrinol. 1992. PMID: 21554664

5

Increase in neurotensin receptor expression in rat brain induced by chronic treatment with the nonpeptide neurotensin receptor antagonist SR 48692.

Azzi M, Nicot A, Gully D, Kitabgi P, Bérod A, Rostène W. Azzi M, et al. Neurosci Lett. 1994 May 19;172(1-2):97-100. doi: 10.1016/0304-3940(94)90671-8. Neurosci Lett. 1994. PMID: 8084546

6

Hypercorticism induces neurotensin mRNA in rat periventricular hypothalamus.

Nicot A, Rostène W, Bérod A. Nicot A, et al. Neuroreport. 1995 Nov 13;6(16):2158-60. doi: 10.1097/00001756-199511000-00015. Neuroreport. 1995. PMID: 8595193

7

[Neurotensin receptor antagonists and therapeutical perspectives].

Gully D, Maffrand JP, Soubrié P, Rostène W, Kitabgi P, Le Fur G. Gully D, et al. Therapie. 1995 Jan-Feb;50(1):5-7. Therapie. 1995. PMID: 7754478 Review. French.

8

Effect of the neurotensin receptor antagonist SR48692 on rat blood pressure modulation by neurotensin.

Gully D, Lespy L, Canton M, Rostène W, Kitabgi P, Le Fur G, Maffrand JP. Gully D, et al. Life Sci. 1996;58(8):665-74. doi: 10.1016/s0024-3205(96)80005-1. Life Sci. 1996. PMID: 8594316

9

Glucocorticoid binding sites in human temporal cortex.

Sarrieau A, Dussaillant M, Sapolsky RM, Aitken DH, Olivier A, Lal S, Rostène WH, Quirion R, Meaney MJ. Sarrieau A, et al. Among authors: rostene wh. Brain Res. 1988 Feb 23;442(1):157-60. doi: 10.1016/0006-8993(88)91444-8. Brain Res. 1988. PMID: 3359250

10

Characterization and distribution of binding sites for a new neurotensin receptor antagonist ligand, [3H]SR 48692, in the guinea pig brain.

Betancur C, Canton M, Gully D, Vela G, Pélaprat D, Rostène W. Betancur C, et al. J Pharmacol Exp Ther. 1995 Jun;273(3):1450-8. J Pharmacol Exp Ther. 1995. PMID: 7791120 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters